title: Veralipride-induced tardive dystonia in a patient with bipolar psychosis.
abstract: Veralipride is a benzamide derivative effective in the treatment of menopausal syndrome. Despite its antidopaminergic action, extrapyramidal side effects seem to be very uncommon. We observed a patient with bipolar psychosis, who developed segmental dystonia after taking the drug. The disorder slowly receded in 14 months, but reappeared during neuroleptic therapy a few months later. To the best of our knowledge, this is the first case of veralipride-induced tardive dystonia, and the affective disorder might have predisposed our patient to the development of this tardive side effect.
authors.affiliation: Servizio di Neurologia, Ospedale Maggiore di Bologna.
authors.forename: A S
authors.initials: AS
authors.lastname: Gabellini
authors.forename: A
authors.initials: A
authors.lastname: Pezzoli
authors.forename: P
authors.initials: P
authors.lastname: De Massis
authors.forename: T
authors.initials: T
authors.lastname: Sacquegna
mesh_terms: D004421:Dystonia / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D011618:Psychotic Disorders / Q000150:complications; D013469:Sulpiride / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D013469:Sulpiride; C027429:veralipride